Zhejiang Hisun Pharmaceutical Co (SHSE:600267) 1-Year Share Buyback Ratio : 0.70% (As of Mar. 2025 )

View and export this data going back to 2000. Start your Free Trial

What is Zhejiang Hisun Pharmaceutical Co 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Zhejiang Hisun Pharmaceutical Co's current 1-Year Share Buyback Ratio was 0.70%.

SHSE:600267's 1-Year Share Buyback Ratio is ranked better than
86.03% of 537 companies
in the Drug Manufacturers industry
Industry Median: -1.9 vs SHSE:600267: 0.70

Competitive Comparison of Zhejiang Hisun Pharmaceutical Co's 1-Year Share Buyback Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Hisun Pharmaceutical Co's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhejiang Hisun Pharmaceutical Co's 1-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Hisun Pharmaceutical Co's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Hisun Pharmaceutical Co's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Zhejiang Hisun Pharmaceutical Co 1-Year Share Buyback Ratio Calculation

Zhejiang Hisun Pharmaceutical Co's 1-Year Share Buyback Ratio for the quarter that ended in Mar. 2025 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Mar. 2024 )	-	Shares Outstanding (EOP) (Mar. 2025 ))	/	Shares Outstanding (EOP) (Mar. 2024 )
	=	(1207.874	-	1198.848)	/	1207.874
	=	0.7%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Hisun Pharmaceutical Co (SHSE:600267) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Zhejiang Hisun Pharmaceutical Co 1-Year Share Buyback Ratio Related Terms

Zhejiang Hisun Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Hisun Pharmaceutical Co Ltd (SHSE:600267) » Definitions » 1-Year Share Buyback Ratio

Traded in Other Exchanges

N/A

Address

No. 46 Waisha Road, Jiaojiang District, Zhejiang Province, Taizhou, CHN, 318000

Website

http://www.hisunpharm.com

Zhejiang Hisun Pharmaceutical Co Ltd is a China-based pharmaceutical company. It is focused on the research, development, and distribution of pharmaceuticals. It produces and supplies antibiotics and anticancer drugs. The company's research channels cover indications like anticancer, cardiovascular, anti-infective, anti-parasitic, immunosuppressant and others. Its product portfolio includes active pharmaceutical ingredients like Anastrozole, Docetaxel, Methotrexate, and others and finished dosages such as letrozole tablets, anastrozole tablets, injection mitomycin, and others.

Executives

Yu Shun Bing	Supervisors
Jin Hong Shun	senior management
Lu Xing Hai	senior management
Zhang Zhen Ying	senior management
Jiang Guo Ping	Director
Yang Zhi Qing	senior management
Du Jia Qiu	senior management
Chen Xiao Hua	Directors, senior managers
Li Yan	Directors, senior managers
Zhao Lei	senior management
Shen Xi Fei	Director
Zhang Wei	senior management
Bai Hua	Director
Chen Li Fei	Supervisors
Hu Liang Bin	senior management

Zhejiang Hisun Pharmaceutical Co Headlines

No Headlines